Shares of Scholar Rock Holding Corporation were traded on the Nasdaq exchange while the FDA approved ISEMBYLD for spinal muscular atrophy.
1 report, 1 independent
Updated Sep 14
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Shares of Scholar Rock Holding Corporation were traded on the Nasdaq exchange while the FDA approved ISEMBYLD for spinal muscular atrophy.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
Related events
- Odyssey Therapeutics, Inc. shares are being traded on the Nasdaq exchange.
- uniQure N.V. traded on the Nasdaq stock exchange and submitted a Biologics License Application (BLA) for accelerated approval of its gene therapy.
- Orthopediatrics traded on the NASDAQ stock exchange on August 26, 2026.
- SAB Biotherapeutics, Inc. began trading on the Nasdaq exchange.
- BrightSpring Health Services stock is trading on the Nasdaq exchange.